Involved‐field high‐dose chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma

Abstract Background We investigated the clinical outcomes of involved‐field high‐dose (≥66 Gy) chemoradiotherapy (CRT) combined with respiratory motion management for esophageal squamous cell carcinoma (ESCC). Methods Patients who underwent definitive CRT for histologically confirmed ESCC in our dep...

Full description

Saved in:
Bibliographic Details
Main Authors: Masaki Matsuda, Takafumi Komiyama, Kan Marino, Shinichi Aoki, Tomoko Akita, Naoki Sano, Hidekazu Suzuki, Masahide Saito, Hikaru Nemoto, Hiroshi Onishi
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.15468
Tags: Add Tag
No Tags, Be the first to tag this record!